Changing a cancerous cell into a normal cell would seem to be the very definition of a holy grail: a lofty goal that is all but impossible to achieve. And yet, it has already been done. It was 1975 when the seminal work of Dr. Beatrice (“Bea”) Mintz showed how…...
A Healthy Thanksgiving
Keeping a healthy and balanced diet is a year-long hassle, but many people grant themselves a bit of leeway around the holidays. With Thanksgiving just around the corner, the warm aroma of turkey and gravy is making nearly everyone anxious for the day of guilt-free indulgence. Unfortunately, there is likely…...
Thanksgiving Recipe: Soup or Side Dish—or Both!
The National Foundation for Cancer Research expresses our appreciation to chef German Lam, a cancer survivor who has been profiled in our Faces & Voices of Cancer—In Depth series, as well as on the FVC website, for offering this delicious base recipe of his to our readers. Perfect for Thanksgiving!…...
Crizotinib Plus Radiation May Reduce NF2-Related Hearing Loss
A study co-authored by National Foundation for Cancer Research Fellow Dr. Rakesh Jain hints that adding the cancer drug crizotinib to the radiation therapy for tumors associated with neurofibromatosis 2 (NF2) may lessen the hearing loss that often precipitates from radiotherapy. Although not a cancer, NF2 is characterized by benign…...
Targeted Lung Cancer Therapy
A Match Made Possible A discovery by a team led by Massachusetts General Hospital’s Daniel Haber, M.D., Ph.D., a physician-scientist supported by the National Foundation for Cancer Research since 2003, now represents a source of hope for many patients with metastatic lung cancer. He and his colleagues correctly linked very…...










